Is there a plant genome project similar to the human genome project?
1000 Plant Genomes Project
While the 1000 Genomes Project has been initially estimated to cost up to $50 million USD, the 1000 Plant Genomes Project will likely not be as expensive; the difference in cost comes from the target sequence in the genomes. Since the 1000 Plant Genomes Project will only be sequencing the transcriptome, whereas the human project will sequence as much of the genome as is decided feasible, there is a much lower amount of sequencing effort needed in this more specific approach. While this means that there will be less overall sequence output relative to the 1000 Genomes Project, the non-coding portions of the genomes excluded in the 1000 Plant Genomes Project are not important to its goals like they are to the human project. So then the more focused approach of the 1000 Plant Genomes Project minimizes cost while still achieving its goals.
Exposome
The idea of a Human Exposome Project, analogous to the Human Genome Project, has been proposed and discussed in numerous scientific meetings, but as of 2017, no such project exists. Given the lack of clarity on how science would go about pursuing such a project, support has been lacking. Reports on the issue include:The concept of the exposome has contributed to the 2010 proposal of a new paradigm in disease phenotype, "the unique disease principle": Every individual has a unique disease process different from any other individual, considering uniqueness of the exposome and its unique influence on molecular pathologic processes including alterations in the interactome. This principle was first described in neoplastic diseases as "the unique tumor principle". Based on this unique disease principle, the interdisciplinary field of molecular pathological epidemiology (MPE) integrates molecular pathology and epidemiology.